CYP1A1 and breast cancer: In conclusion, our results suggest that polymorphisms in CYP1A1 (Val) and CYP17 (A1) are associated with increased BC risk among Inuit women and this risk is increased in women having higher serum levels of PFASs (PFOS/PFOA).